As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.  

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

PODCAST: Dr. Warren Kibbe & Dr. Henry Rodriguez: Working toward a cure for cancer

The Obama administration's cancer moonshot has brought three Federal agencies together. Specifically, the National Cancer Institute (NCI), the Department of Defense (DoD), and the Department of Veterans Affairs (VA) have formed a new collaboration using state-of-the-art research methods in proteogenomics to more rapidly identify unique targets and pathways of cancer for detection and intervention. The APOLLO Network -  Applied Proteogenomics OrganizationaL Learning and Outcomes - will look at both a patient’s genes (genomic analysis) and the expression of these genes in the form of proteins (proteomic analysis) to create the nation’s first system in which cancer patients are routinely screened for genomic abnormalities and proteomic information to match their tumor types to targeted therapies. 

Dr. Henry Rodriguez, director of Proteo-genomics Research, and Dr. Warren Kibbe, director of the Center for Biomedical Informatics and Information Technology at NCI, join Federal Drive with Tom Temin to discuss what the Institute is bringing to the consortium.